Advertisement
UK markets open in 2 hours 39 minutes
  • NIKKEI 225

    37,711.11
    -748.97 (-1.95%)
     
  • HANG SENG

    17,295.93
    +94.66 (+0.55%)
     
  • CRUDE OIL

    82.90
    +0.09 (+0.11%)
     
  • GOLD FUTURES

    2,325.90
    -12.50 (-0.53%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • Bitcoin GBP

    51,469.16
    -2,040.62 (-3.81%)
     
  • CMC Crypto 200

    1,389.41
    -34.69 (-2.44%)
     
  • NASDAQ Composite

    15,712.75
    +16.11 (+0.10%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%

Here's How Moderna Turned a Profit in Q1 Despite Its Sales Declining by 69%

Moderna (NASDAQ: MRNA) surprised investors last quarter when it didn't incur a loss despite a significant drop in sales. For the first three months of 2023, Moderna's revenue totaled just under $1.9 billion, which is just a fraction of the $6.1 billion it reported in the same period last year. Meanwhile, its operating expenses, totaling $2.2 billion, rose by more than 21%.